ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1489

Development and Validation of a Questionnaire to Assess Healthcare Utilization and Access in Cohorts of Patients with Primary Sjögren’s Syndrome

Chiara Seghieri1, Chiara Baldini2, Luca Quartuccio3, Francesco Ferro4, Saviana Gandolfo5, Salvatore De Vita6 and Stefano Bombardieri4, 1Istituto di Management Scuola Superiore Sant'Anna, Pisa, Italy, 2Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 3Rheumatology Clinic, DSMB, University of Udine, Udine, Italy, Udine, Italy, 4Rheumatology Unit, University of Pisa, Pisa, Italy, 5Rheumatology Clinic, Medical Area Department, University of Udine, Udine, Italy, 6Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: health care cost and questionnaires, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Sjögren's Syndrome Poster II: Clinical Research

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The geographic variation in healthcare service utilization and quality across and within countries is well documented. Part of this geographic variation is linked to differences in population health and needs. However, some of the variation may be unwarranted and driven by factors other than health needs, such as provider discretion, the availability and distribution of resources, financing and reimbursement models (Wennberg 2011). In this study, we identified the need for instuments to collect comparable data in Europe to establish practice profiles in the treatment and management of patients with Primary Sjögren’s Syndrome (pSS).

Methods: We describe the development and preliminary validation of a questionnaire to pSS to collect information on access to and intensity of treatments and services (e.g. diagnostic testing, hospitalizations, specialist visits), patients’ satisfaction with the care received and socio-demographic data (e.g. age, sex, education level). A short questionnaire is also administered to specialists treating the selected pSS to collect data on the organization of the clinical centers and involvement and relations with other healthcare professionals besides clinical information of the selected patients.

Results: The pilot version of the questionnaire was administered to 50 pSS in the clinical centre of Pisa (Italy) and counted 22 closed-ended questions. Three questionnaires out of 50 were returned incomplete. Mean (SD) age was 60 (12.2) years and 96% of the sample was female. The majority of the respondents had a primary or secondary school (59%). Construct validity was supported by the questionnaire’s ability to discriminate between groups with different levels of activity of the disease and socio-demographic characteristics. Disease activity was significantly associated with frequency of rheumatologic visits and diagnostic tests (p<0.001). The total number of specialists involved in the care other than the rheumatologist varies significantly among patients. As expected, the most frequently involved were the ophthalmologist (90%) and the dentist (58%). Additionally, patients with lower education have attended on average less specialists than those with a high school or university degree (p<0.001).

Conclusion: Preliminary results confirm that the questionnaire is a valid instrument to assess patterns of care for pSS in terms of access and utilization and in relation to clinical and socio-demographic characterictics of patients. Further analysis will be conducted in other clinical centers within the European Horizon 2020 project “HarmonicSS” to verify the generalizability and additional psychometric properties of the instrument.


Disclosure: C. Seghieri, None; C. Baldini, None; L. Quartuccio, None; F. Ferro, None; S. Gandolfo, None; S. De Vita, None; S. Bombardieri, None.

To cite this abstract in AMA style:

Seghieri C, Baldini C, Quartuccio L, Ferro F, Gandolfo S, De Vita S, Bombardieri S. Development and Validation of a Questionnaire to Assess Healthcare Utilization and Access in Cohorts of Patients with Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/development-and-validation-of-a-questionnaire-to-assess-healthcare-utilization-and-access-in-cohorts-of-patients-with-primary-sjo%cc%88grens-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-validation-of-a-questionnaire-to-assess-healthcare-utilization-and-access-in-cohorts-of-patients-with-primary-sjo%cc%88grens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology